Mydecine Innovations Financials

Mydecine Innovations Stock Summary

Mydecine Innovations Group Inc., a biotech and life sciences company, engages in the development and commercialization of drugs for treating mental health problems. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada. Mydecine Innovations operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 11 people.

Mydecine Innovations Key Financial Ratios

There are many critical financial ratios that Mydecine Innovations' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Mydecine Innovations reports annually and quarterly.

Mydecine Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Mydecine Innovations's current stock value. Our valuation model uses many indicators to compare Mydecine Innovations value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mydecine Innovations competition to find correlations between indicators driving Mydecine Innovations's intrinsic value. More Info.Mydecine Innovations Group is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mydecine Innovations' earnings, one of the primary drivers of an investment's value.

Mydecine Innovations Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Mydecine Innovations help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Mydecine Innovations Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of Mydecine Innovations Group based on widely used predictive technical indicators. In general, we focus on analyzing Mydecine Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Mydecine Innovations's daily price indicators and compare them against related drivers.

When running Mydecine Innovations' price analysis, check to measure Mydecine Innovations' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mydecine Innovations is operating at the current time. Most of Mydecine Innovations' value examination focuses on studying past and present price action to predict the probability of Mydecine Innovations' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mydecine Innovations' price. Additionally, you may evaluate how the addition of Mydecine Innovations to your portfolios can decrease your overall portfolio volatility.